197 related articles for article (PubMed ID: 2463611)
1. A canine model of torsades de pointes.
Leichter D; Danilo P; Boyden P; Rosen TS; Rosen MR
Pacing Clin Electrophysiol; 1988 Dec; 11(12):2235-45. PubMed ID: 2463611
[TBL] [Abstract][Full Text] [Related]
2. Experimental models of torsades de pointes.
Weissenburger J; Davy JM; Chézalviel F
Fundam Clin Pharmacol; 1993; 7(1):29-38. PubMed ID: 8458600
[TBL] [Abstract][Full Text] [Related]
3. Epicardial activation patterns of torsade de pointes in canine hearts with quinidine-induced long QT interval but without myocardial infarction.
Inoue H; Murakawa Y; Toda I; Nozaki A; Matsuo H; Mashima S; Sugimoto T
Am Heart J; 1986 Jun; 111(6):1080-7. PubMed ID: 3716981
[TBL] [Abstract][Full Text] [Related]
4. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart.
Asano Y; Davidenko JM; Baxter WT; Gray RA; Jalife J
J Am Coll Cardiol; 1997 Mar; 29(4):831-42. PubMed ID: 9091531
[TBL] [Abstract][Full Text] [Related]
5. Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole.
Yamamoto K; Tamura T; Imai R; Yamamoto M
Toxicol Sci; 2001 Mar; 60(1):165-76. PubMed ID: 11222883
[TBL] [Abstract][Full Text] [Related]
6. A mechanism of torsades de pointes in a canine model.
Bardy GH; Ungerleider RM; Smith WM; Ideker RE
Circulation; 1983 Jan; 67(1):52-9. PubMed ID: 6847804
[TBL] [Abstract][Full Text] [Related]
7. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
[TBL] [Abstract][Full Text] [Related]
8. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
Lin JC; Quasny HA
Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
[TBL] [Abstract][Full Text] [Related]
9. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
[TBL] [Abstract][Full Text] [Related]
10. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia.
Tran HT; Chow MS; Kluger J
Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2275-8. PubMed ID: 9309756
[TBL] [Abstract][Full Text] [Related]
13. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.
Morganroth J
Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748
[TBL] [Abstract][Full Text] [Related]
14. Torsades de pointes and ventricular fibrillation in a canine model of quinidine-induced QT prolongation.
Inoue H; Sugimoto T
Ann N Y Acad Sci; 1992 Jan; 644():93-102. PubMed ID: 1562122
[No Abstract] [Full Text] [Related]
15. Terminology of torsades de pointes.
Tzivoni D; Keren A; Banai S; Stern S
Cardiovasc Drugs Ther; 1991 Apr; 5(2):505-7. PubMed ID: 1854659
[TBL] [Abstract][Full Text] [Related]
16. Greater quinidine-induced QTc interval prolongation in women.
Benton RE; Sale M; Flockhart DA; Woosley RL
Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
Roden DM; Woosley RL; Primm RK
Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
[TBL] [Abstract][Full Text] [Related]
18. Mexiletine: long-term follow-up of a patient with prolonged QT interval and quinidine-induced torsades de pointes.
Thomas MG; Giles TD
South Med J; 1985 Feb; 78(2):205-6. PubMed ID: 3919448
[TBL] [Abstract][Full Text] [Related]
19. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists.
Gilbert JD; Cahill SA; McCartney DG; Lukas A; Gross GJ
Can J Physiol Pharmacol; 2000 May; 78(5):407-14. PubMed ID: 10841436
[TBL] [Abstract][Full Text] [Related]
20. [An experimental model of helicoid ventricular tachycardia (torsades de pointes). Preliminary report].
Romero Ayala LC; Medrano GA; Cárdenas Loaeza M; Clemente AC
Arch Inst Cardiol Mex; 1987; 57(1):67-72. PubMed ID: 2952093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
